IGF1R immunohistochemistry in Ewing's sarcoma as predictor of response to targeted therapy.

Int J Health Sci (Qassim) · 2020 · PMC7346972 · PMID 32694968

Europe PMC

hedged sentence

0.0534

closest p · 1.1× alpha

0.0534

boldest claim

The sentences

showed a trendP = 0.0534so close (0.05 < p ≤ 0.1)

High staining also showed a trend, albeit statistically insignificant, association with advanced tumors (regional extension + metastatic) ( P = 0.0534).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.